The population dynamics of cancer: A Darwinian perspective

International Journal of Epidemiology

Volumn 35, Issue 5, 2006, Pages 1151-1159

  Vineis, Paolo ^a   Berwick, Marianne ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CAROTENOID; ERLOTINIB; FINASTERIDE; FLAVONOID; GEFITINIB; HEPATITIS B VACCINE; INSULIN; MUTAGENIC AGENT; RETINOL;

CANCER; CARCINOGEN; MUTAGENICITY; MUTATION; PHENOTYPE; POPULATION DYNAMICS;

ANALYSIS OF VARIANCE; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER MODEL; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ENVIRONMENTAL FACTOR; EPIGENETICS; ESOPHAGUS CANCER; EVOLUTION; GENE INTERACTION; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; HYPERINSULINEMIA; LIVER CANCER; LUNG CANCER; LYMPHATIC LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NONHUMAN; PANCREAS CANCER; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; POPULATION DYNAMICS; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; SOMATIC MUTATION; STOMACH CANCER; SUNLIGHT; VASCULAR RESISTANCE; VITAMIN SUPPLEMENTATION;

CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; ENVIRONMENTAL EXPOSURE; EVOLUTION, MOLECULAR; HUMANS; MALE; MODELS, BIOLOGICAL; MUTAGENS; MUTATION; NEOPLASMS; SELECTION (GENETICS); SELECTION, GENETIC;

EID: 33750202014     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyl185     Document Type: Article

References (61)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol 1999;9:M57-60.
3. Iscovich J, Howe GR. Cancer incidence patterns (1972-91) among migrants from the Soviet Union to Israel. Cancer Causes Control 1998;9:29-36.
4. Iscovich J, Parkin DM. Risk of cancer in migrants and their descendants in Israel: I. Leukaemias and lymphomas. Int J Cancer 1997;70:649-53.
5. Swerdlow AJ, Marmot MG, Grulich AE, Head J. Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales. Br J Cancer 1995;72:1312-19.
6. Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis and age at migration. Cancer Causes Control 1991;2:401-11.
7. McCredie M, Williams S, Coates M. Cancer mortality in migrants from the British Isles and continental Europe to New South Wales, Australia, 1975-1995. Int J Cancer 1999;83:179-85.
8. Thomas DB, Karagas MR. Cancer in first and second generation Americans. Cancer Res 1987;47:5771-76.
9. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005;14:243-50.
10. Goodman GE, Thornquist MD, Balmes J et al. The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping betacarotene and retinol supplements. J Natl Cancer Inst 2004;96: 1743-50.
11. IARC Working Group on the Evaluation of Cancer Preventive Agents. IARC handbooks of cancer prevention. Vol. 2, Carotenoids. Lyon, France: IARC Scientific Publications, 1998.
12. Bohnsack BL, Hirschi KK. Nutrient regulation of cell cycle progression. Annu Rev Nutr 2004;24:433-53.
13. Barnard RJ, Aronson WJ. Preclinical models relevant to diet, exercise, and cancer risk. Recent Results Cancer Res 2005;166:47-61.
14. Reynolds T. Prostate cancer prevention trial yields positive results, but with a few cautions. J Natl Cancer Inst 2003;95:1030-01.
15. Makridakis NM, Buchanan G, Tilley W, Reichardt JK. Androgen metabolic genes in prostate cancer predisposition and progression. Front Biosci 2005;10:2892-903.
16. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 1995;60:489-94.
17. Maldonado JL, Fridlyand J, Patel H et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003;95: 1878-90.
18. Cohen Y, Rosenbaum E, Begum S et al. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 2004;10:3444-47.
19. Andersen MH, Fensterle J, Ugurel S et al. Immunogenicity of constitutively active V599EBRaf. Cancer Res 2004;64:5456-60.
20. Fensterle J, Becker JC, Potapenko T et al. B-Raf specific antibody responses in melanoma patients. BMC Cancer 2004;4:62.
21. Sharkey MS, Lizee G, Gonzales MI, Patel S, Topalian SL. CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation. Cancer Res 2004;64:1595-99.
22. Pao W, Miller VA, Politi KA et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005;2:e73.
23. Li R, Hehlman R, Sachs R, Duesberg P. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells. Cancer Genet Cytogenet 2005;163:44-56.
24. Bardelli A, Cahill DP, Lederer G et al. Carcinogen-specific induction of genetic instability. Proc Natl Acad Sci USA 2001;98:5770-75.
25. Mori H, Colman SM, Xiao Z et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002;99:8242-47.
26. Finette BA, Homans AC, Rivers J, Messier T, Albertini RJ. Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia. Leukemia 2001;15:1898-905.
27. Somers CM, Yauk CL, White PA, Parfett CL, Quinn JS. Air pollution induces heritable DNA mutations. Proc Natl Acad Sci USA 2002;99:15904-07.
28. Perera F, Hemminki K, Jedrychowski W et al. In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiol Biomarkers Prev 2002;11:1134-37.
29. Selevan SG, Borkovec L, Slott VL et al. Semen quality and reproductive health of young Czech men exposed to seasonal air pollution. Environ Health Perspect 2000;108:887-94.
30. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004;567:447-74.
31. Whyatt RM, Jedrychowski W, Hemminki K et al. Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. Cancer Epidemiol Biomarkers Prev 2001;10:581-88.
32. Bocskay KA, Tang D, Orjuela MA, Liu X, Warburton DP, Perera FP. Chromosomal aberrations in cord blood are associated with prenatal exposure to carcinogenic polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev 2005;14:506-11.
33. Maciag A, Bialkowska A, Espiritu I et al. Gestation stage-specific oxidative deoxyribonucleic acid damage from sidestream smoke in pregnant rats and their fetuses. Arch Environ Health 2003;58:238-44.
34. Zhou G, Hernandez NS, Randerath E, Randerath K. Effects of different diets and dietary restriction on perinatal endogenous DNA adducts. Time dependence of oxidative and presumptive nonoxidative lesions. Mutat Res 2000;447:137-47.
35. Bessler M, Schaefer A, Keller P. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology. Transfus Med Rev 2001;15:255-67.
36. Tannock I. Cell kinetics and chemotherapy: A critical review. Cancer Treat Rep 1978;62:1117-33.
37. Fischer AH, Young KA, DeLellis RA. Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development. J Cell Biochem 2004;93:28-36.
38. Michod R. Darwinian Dynamics. Princeton: Princeton University Press, 2000.
39. Gatenby RA. Application of competition theory to tumour growth: implications for tumour biology and treatment. Eur J Cancer 1996;32A:722-26.
40. Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res 2003;63:6212-20.
41. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 2003;38:302-06.
42. Little MP, Wright EG. A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Math Biosci 2003;183:111-34.
43. Breivik J. The evolutionary origin of genetic instability in cancer development. Semin Cancer Biol 2005;15:51-60.
44. Davis BD. Transcriptional bias: A non-Lamarckian mechanism for substrate-induced mutations. Proc Natl Acad Sci USA 1989;86:5005-09.
45. Rosenberg SM, Thulin C, Harris RS: Transient and heritable mutators in adaptive evolution in the lab and in nature. Genetics 1998;148:1559-66.
46. Bjedov I, Tenaillon O, Gerard B et al. Stress-induced mutagenesis in bacteria. Science 2003;300:1404-09.
47. Hall BG. Spontaneous point mutations that occur more often when advantageous than when neutral. Genetics 1990;126:5-16.
48. Harris RS, Feng G, Ross KJ et al. Mismatch repair is diminished during stationary-phase mutation. Mutat Res 1999;437:51-60.
49. Harris RS, Feng G, Ross KJ et al. Mismatch repair protein MutL becomes limiting during stationary-phase mutation. Genes Dev 1997;11:2426-37.
50. Jin YH, Clark AB, Slebos RJC et al. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nature Genetics 2003;14:326-29.
51. Lewontin R. The analysis of variance and the analysis of causes. Am J Human Genetics 1972;26:400-11. Reprinted in Int J Epidemiol June 2006.
52. Pigliucci M. Phenotypic Plasticity. Baltimore: The Johns Hopkins University Press, 2001, p. 5.
53. Ottman R. Gene-environment interaction: Definitions and study designs. Prev Med 1996;25:764-70.
54. Suzuki Y, Nijhout HF. Evolution of a polyphenism by genetic accommodation. Science 2005;311:650-52.
55. Jablonka E, Lamb MJ. Evolution in Four Dimensions. Cambridge: MIT Press, 2005.
56. Cooney C, Dave A, Wolff G. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002;138:2393S-2400S.
57. Waterland R, Jirtle R. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63-68.
58. Charlton BG. Is immortality a possibility? A thought experiment concerning the inevitability of senescence due to endogenous parasitism. Perspect Biol Med 1995;39:146-49.
59. Greaves M. Cancer causation: The Darwinian downside of past success? Lancet Oncol 2002;3:244-51.
60. Weiss KM. Is there a paradigm shift in genetics? Lessons from the study of human diseases. Mol Phylogenet Evol 1996;5:259-65.
61. Vineis P, Husgafvel-Pursiainen K. Air pollution and cancer: Biomarker studies in human populations. Carcinogenesis 2005;26:1846-55.